CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
4.19 NOK
-0.11 (-2.56%)
Overall CONTX gets a fundamental rating of 6 out of 10. We evaluated CONTX against 10 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
CONTX had a positive operating cash flow in the past year.
Of the past 5 years CONTX 4 years were profitable.
Each year in the past 5 years CONTX had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CONTX (7.66%) is better than 63.64% of its industry peers.
The Return On Equity of CONTX (10.25%) is better than 63.64% of its industry peers.
CONTX's Return On Invested Capital of 8.96% is fine compared to the rest of the industry. CONTX outperforms 72.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 9.28%.
The last Return On Invested Capital (8.96%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a better Profit Margin (7.86%) than 63.64% of its industry peers.
In the last couple of years the Profit Margin of CONTX has grown nicely.
With a decent Operating Margin value of 9.33%, CONTX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
CONTX's Operating Margin has improved in the last couple of years.
The Gross Margin of CONTX (97.46%) is better than 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
The Debt to FCF ratio of CONTX (1.49) is better than 63.64% of its industry peers.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.07, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.08%
2.3 Liquidity
CONTX has a Current Ratio of 4.12. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.12, CONTX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
CONTX has a Quick Ratio of 4.07. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX has a better Quick ratio (4.07) than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.32% over the past year.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
Looking at the last year, CONTX shows a quite strong growth in Revenue. The Revenue has grown by 12.19% in the last year.
The Revenue has been growing slightly by 7.78% on average over the past years.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
The Earnings Per Share is expected to decrease by -13.34% on average over the next years. This is quite bad
The Revenue is expected to decrease by -1.19% on average over the next years.
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.11, which indicates a very decent valuation of CONTX.
Based on the Price/Earnings ratio, CONTX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CONTX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.92.
The Forward Price/Earnings Ratio is negative for CONTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.11 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CONTX.
CONTX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.47 | ||
| EV/EBITDA | 12.3 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -35.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.06, CONTX pays a better dividend. On top of this CONTX pays more dividend than 81.82% of the companies listed in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
OSL:CONTX (12/23/2025, 7:00:00 PM)
4.19
-0.11 (-2.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap324.18M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (-2.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.52%
Revenue NY rev (3m)-11.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.11 | ||
| Fwd PE | N/A | ||
| P/S | 2.49 | ||
| P/FCF | 50.47 | ||
| P/OCF | 21.77 | ||
| P/B | 3.25 | ||
| P/tB | 3.35 | ||
| EV/EBITDA | 12.3 |
EPS(TTM)0.46
EY10.98%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.08
FCFY1.98%
OCF(TTM)0.19
OCFY4.59%
SpS1.68
BVpS1.29
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.08%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 8 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 7 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.